Di Zhu

机构：Kunming University of Science and Technology, Ministry of Education of the People's Republic of China, Anhui University, Kunming University, Hefei University of Technology, Capital Medical University · ORCID：0000-0002-8959-2596

发表论文 57 篇 · 总被引 1134 次 · h-index 18

代表论文

• PAD4 and Its Inhibitors in Cancer Progression and Prognosis (2022 · Pharmaceutics · 被引 73)
• Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy (2022 · Nanoscale · 被引 65)
• PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis (2024 · Advanced Science · 被引 30)
• Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment (2021 · Acta Pharmaceutica Sinica B · 被引 30)
• Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells (2022 · Pharmaceutical Biology · 被引 28)
• Developmental toxicity of fenbuconazole in zebrafish: Effects on mitochondrial respiration and locomotor behavior (2022 · Toxicology · 被引 27)